Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nicholas Crosby

Hand Surgery Indianapolis, IN Medical Doctor

NPI 1285892877 CMS profile 57918

8501 Harcourt Rd, Indianapolis, IN 46260

Open in the dashboard

General payments

$17,569

74 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicholas Crosby of Indianapolis, IN is reported in the CMS Open Payments database as having received $17,569 across 74 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $848 12
2024 General $2,934 8
2023 General $4,712 15
2022 General $2,995 8
2021 General $1,773 10
2020 General $473 8
2019 General $3,835 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicholas Crosby
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Nicholas Crosby were reported at $848. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Nicholas Crosby Hand Surgery median Middle half National median
2019 $3,835 $383 $106–$1,905 $163
2020 $473 $172 $51–$1,268 $114
2021 $1,773 $263 $71–$1,591 $132
2022 $2,995 $336 $87–$1,938 $149
2023 $4,712 $233 $81–$1,114 $160
2024 $2,934 $258 $88–$1,203 $164
2025 $848 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Acumed LLC $7,127 16 payments
  2. Crossroads Orthopedics, LLC $3,698 8 payments
  3. Trice Medical, Inc. $3,495 7 payments
  4. Djo, LLC $425 10 payments
  5. Zimmer Biomet Holdings, Inc. $415 4 payments
  6. AxoGen $371 3 payments
  7. Integra LifeSciences Corporation $339 3 payments
  8. Stryker Corporation $317 3 payments
  9. DePuy Synthes Sales Inc. $287 3 payments
  10. Wright Medical Technology, Inc. $151 1 payment
  11. Other $945 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $8,528 6 payments
  2. Food and Beverage $4,121 61 payments
  3. Education $3,720 5 payments
  4. Travel and Lodging $1,200 2 payments
Products named General payments · program years 2019–2025
  1. ACUMED Hand & Wrist $6,540 11 payments
  2. Segway blade or mieye camera $3,062 3 payments
  3. ACUMED Hand & Wrist $2,600 1 payment
  4. ACUMED Hand & Wrist $2,534 2 payments
  5. AxoGuard Nerve Connector $243 2 payments
  6. AXOGUARD NERVE PROTECTOR $243 2 payments
  7. INnate Implant $206 6 payments
  8. ACUMED Screw & Pin $206 6 payments
  9. PSI Anatomical Shoulder $180 2 payments
  10. CMF $176 4 payments
  11. Other $3,842 48 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 104 billing codes

Paid by Medicare

$130,889

Of which drugs: $10,417

Medicare patients

323

Average age 74

Services billed

1,309

208 women, 115 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Diabetes 31%
Depression 29%
Ischemic heart disease 25%
Chronic kidney disease 25%
Osteoporosis 18%
COPD 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 49 112 $581
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 11 40 $30

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

74 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record